<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39625388</PMID><DateCompleted><Year>2025</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Insights Into the Group of Surgically Resectable But Nonoperable Patients With Colorectal Cancer.</ArticleTitle><Pagination><StartPage>351</StartPage><EndPage>358</EndPage><MedlinePgn>351-358</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003580</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The incidence of colorectal cancer is expected to increase, particularly among patients with significant frailty and comorbidities. A subgroup of these patients may not be suitable for surgery because of the high risk of postoperative morbidity and mortality.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to characterize the clinical outcomes, management, social status, and survival of patients deemed nonoperable because of comorbidity and/or frailty.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">This was a retrospective cohort study.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">Overall survival was estimated using the Kaplan-Meier method. The Cox proportional-hazards model was used to estimate HRs and 95% CIs for mortality-associated modifiable risk factors.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Patients diagnosed with resectable colorectal cancer but deemed nonoperable because of comorbidity and/or frailty by a multidisciplinary team between January 1, 2020, and April 30, 2024, were included in this study.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">The primary outcome was to describe the current population, investigate mortality, and explore mortality-related risk factors in the current population.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During the study period, 69 of 1667 patients who had colorectal cancer that was potentially resectable but who were deemed nonoperable were included in the study population. The rate of 90-day and 1-year mortality was 20% and 52%, respectively. Three years after the diagnosis, 12% of the patients were alive. At the time of diagnosis, anemia was found in 73% of female patients and 71% of male patients. In addition, 77% of the patients had hypoalbuminemia. Lower albumin levels were associated with poor survival (HR, 0.92; 95% CI, 0.88-0.98; p = 0.007).</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">The retrospective nature and small sample size inherently limit the generalizability of the study findings.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Mortality in the current population was high. However, our findings highlight potential areas for improvement in the management of these patients. See Video Abstract .</AbstractText><AbstractText Label="INFORMACIN SOBRE EL GRUPO DE PACIENTES CON CNCER COLORRECTAL RESECABLES QUIRRGICAMENTE PERO NO OPERABLES" NlmCategory="UNASSIGNED">ANTECEDENTES:Se espera que la incidencia del c&#xe1;ncer colorrectal aumente, en particular entre los pacientes con fragilidad y comorbilidades significativas. Un subgrupo de estos pacientes puede no ser apto para la cirug&#xed;a debido al alto riesgo de morbilidad y mortalidad posoperatorias.OBJETIVO:El objetivo de este estudio fue caracterizar los resultados cl&#xed;nicos, el tratamiento, el estado social y la supervivencia de los pacientes considerados no operables debido a la comorbilidad y/o fragilidad.DISE&#xd1;O:Este fue un estudio de cohorte retrospectivo.ESTABLECIMIENTOS:La supervivencia general se estim&#xf3; utilizando el m&#xe9;todo de Kaplan-Meier. Se utiliz&#xf3; el modelo de riesgos proporcionales de Cox para estimar los cocientes de riesgo y los intervalos de confianza del 95% para los factores de riesgo modificables asociados a la mortalidad.PACIENTES:Se incluyeron en este estudio pacientes diagnosticados con c&#xe1;ncer colorrectal resecable pero considerados no operables debido a la comorbilidad y/o fragilidad por un equipo multidisciplinario entre el 1 de enero de 2020 y el 30 de abril de 2024.PRINCIPALES MEDIDAS DE RESULTADOS:El resultado primario fue describir la poblaci&#xf3;n actual, investigar la mortalidad y explorar los factores de riesgo relacionados con la mortalidad en esta poblaci&#xf3;n.RESULTADOS:Durante el per&#xed;odo del estudio, 69 de 1667 pacientes eran potencialmente resecables pero se los consider&#xf3; no operables y se los incluy&#xf3; en la poblaci&#xf3;n del estudio. La tasa de mortalidad a los 90 d&#xed;as y al a&#xf1;o fue del 20% y del 52%, respectivamente. Tres a&#xf1;os despu&#xe9;s del diagn&#xf3;stico, el 12% de los pacientes estaban vivos. En el momento del diagn&#xf3;stico, se encontr&#xf3; anemia en el 73% de las pacientes femeninas y en el 71% de los pacientes masculinos. Adem&#xe1;s, el 77% de los pacientes ten&#xed;an hipoalbuminemia. Los niveles m&#xe1;s bajos de alb&#xfa;mina se asociaron con una supervivencia deficiente, &#xed;ndice de riesgo de 0,92 (intervalo de confianza del 95%: 0,88-0,98, p = 0,007).LIMITACIONES:La naturaleza retrospectiva y el peque&#xf1;o tama&#xf1;o de la muestra limitan inherentemente la generalizaci&#xf3;n de los hallazgos del estudio.CONCLUSIONES:La mortalidad en la poblaci&#xf3;n actual fue alta. Sin embargo, nuestros hallazgos resaltan &#xe1;reas potenciales para mejoras en el manejo de estos pacientes. (Traducci&#xf3;n-Dr. Felipe Bellolio ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ose</LastName><ForeName>Ilze</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-7018-9414</Identifier><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orhan</LastName><ForeName>Adile</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eraslan</LastName><ForeName>Sule</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;genur</LastName><ForeName>Enise</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexandersen</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Righult</LastName><ForeName>Angelina Astrid</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayhan</LastName><ForeName>Emine Ceren</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Amalie Thomsen</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saqi</LastName><ForeName>Ida Kolukisa</ForeName><Initials>IK</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;genur</LastName><ForeName>Ismail</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Center for Surgical Science, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Danish Colorectal Cancer Group, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="Y">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="Y">Frailty</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>20</Day><Hour>18</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>3</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>3</Day><Hour>10</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39625388</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003580</ArticleId><ArticleId IdType="pii">00003453-990000000-00816</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209&#x2013;249.</Citation></Reference><Reference><Citation>eurostat. Statistics Explained. Ageing Europe&#x2013;statistics on population developments. https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Ageing_Europe_-_statistics_on_population_developments#Older_people_.E2.80.94_population_overview . Accessed June 10, 2024.</Citation></Reference><Reference><Citation>Ose I, Rosen AW, Br&#xe4;uner K, et al. The association of postoperative morbidity and age on 5-year survival after colorectal surgery in the elderly population: a nationwide cohort study. Colorectal Dis. 2024;26:899&#x2013;915.</Citation></Reference><Reference><Citation>Van Walree IC, Scheepers E, van Huis-Tanja L, et al. A systematic review on the association of the G8 with geriatric assessment, prognosis and course of treatment in older patients with cancer. J Geriatr Oncol. 2019;10:847&#x2013;858.</Citation></Reference><Reference><Citation>Bojesen RD, Dalton SO, Skou ST, et al. Preoperative multimodal prehabilitation before elective colorectal cancer surgery in patients with WHO performance status I or II: randomized clinical trial. BJS Open. 2023;7:zrad134.</Citation></Reference><Reference><Citation>Heger P, Probst P, Wiskemann J, Steindorf K, Diener MK, Mihaljevic AL. A systematic review and meta-analysis of physical exercise prehabilitation in major abdominal surgery (PROSPERO 2017 CRD42017080366). J Gastrointest Surg. 2020;24:1375&#x2013;1385.</Citation></Reference><Reference><Citation>Brierley J, Gospodarowicz MD, Wittekind CT. Oesophagus and oesophagogastric junction. In: Brierley J, Gospodarowicz MD, Wittekind CT, eds. TNM Classification of Malignant Tumors International Union Against Cancer. 8th ed. Oxford, England: Wiley; 2017:57&#x2013;62.</Citation></Reference><Reference><Citation>Kopp VJ. Use of the American Society of Anesthesiologists physical status classification system in research. Anesth Analg. 2013;117:752.</Citation></Reference><Reference><Citation>Azam F, Latif MF, Farooq A, et al. Performance status assessment by using ECOG (Eastern Cooperative Oncology Group) score for cancer patients by oncology healthcare professionals. Case Rep Oncol. 2019;12:728&#x2013;736.</Citation></Reference><Reference><Citation>Domenica Cappellini M, Motta I. Anemia in clinical practice-definition and classification: does hemoglobin change with aging? Semin Hematol. 2015;52:261&#x2013;269.</Citation></Reference><Reference><Citation>The Danish Colorectal Cancer Group. Klinisk Retningslinjer &#x2502;Kraeft DCCG version 2.0. www.dccg.dk/retningslinjer . Accessed June 15, 2024.</Citation></Reference><Reference><Citation>Hardt J, Pilz L, Magdeburg J, Kienle P, Post S, Magdeburg R. Preoperative hypoalbuminemia is an independent risk factor for increased high-grade morbidity after elective rectal cancer resection. Int J Colorectal Dis. 2017;32:1439&#x2013;1446.</Citation></Reference><Reference><Citation>Jerath A, Austin PC, Wijeysundera DN. Days alive and out of hospital: validation of a patient-centered outcome for perioperative medicine. Anesthesiology. 2019;131:84&#x2013;93.</Citation></Reference><Reference><Citation>Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996;17:343&#x2013;346.</Citation></Reference><Reference><Citation>Von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453&#x2013;1457.</Citation></Reference><Reference><Citation>Lidder PG, Sanders G, Whitehead E, et al. Pre-operative oral iron supplementation reduces blood transfusion in colorectal surgery&#x2014;a prospective, randomised, controlled trial. Ann R Coll Surg Engl. 2007;89:418&#x2013;421.</Citation></Reference><Reference><Citation>Wilson MJ, van Haaren M, Harlaar JJ, et al. Long-term prognostic value of preoperative anemia in patients with colorectal cancer: a systematic review and meta-analysis. Surg Oncol. 2017;26:96&#x2013;104.</Citation></Reference><Reference><Citation>Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011&#x2013;1023.</Citation></Reference><Reference><Citation>Hu WH, Eisenstein S, Parry L, Ramamoorthy S. Preoperative malnutrition with mild hypoalbuminemia associated with postoperative mortality and morbidity of colorectal cancer: a propensity score matching study. Nutr J. 2019;18:33.</Citation></Reference><Reference><Citation>Haskins IN, Baginsky M, Amdur RL, Agarwal S. Preoperative hypoalbuminemia is associated with worse outcomes in colon cancer patients. Clin Nutr. 2017;36:1333&#x2013;1338.</Citation></Reference><Reference><Citation>Mullen MG, Michaels AD, Mehaffey HJ, et al. Risk associated with complications and mortality after urgent surgery vs elective and emergency surgery: implications for defining &#x201c;quality&#x201d; and reporting outcomes for urgent surgery. JAMA Surg. 2017;152:768&#x2013;774.</Citation></Reference><Reference><Citation>Leicher LW, Huisman JF, Van Grevenstein WMU, et al. Colonoscopic-assisted laparoscopic wedge resection for colonic lesions: a prospective multicenter cohort study (LIMERIC-Study). Ann Surg. 2022;275:933&#x2013;939.</Citation></Reference><Reference><Citation>Zwager LW, Bastiaansen BAJ, Van Der Spek BW, et al.; Dutch eFTR Group. Endoscopic full-thickness resection of T1 colorectal cancers: a retrospective analysis from a multicenter Dutch eFTR registry. Endoscopy. 2022;54:475&#x2013;485.</Citation></Reference><Reference><Citation>Hartwig MFS, Bulut M, Ravn-Eriksen J, et al. Combined endoscopic and laparoscopic surgery (CELS) for early colon cancer in high-risk patients. Surg Endosc. 2023;37:8511&#x2013;8521.</Citation></Reference><Reference><Citation>Ha RK, Park B, Han KS, et al. Subpopulation analysis of survival in high-risk T1 colorectal cancer: surgery versus endoscopic resection only. Gastrointest Endosc. 2022;96:1036&#x2013;1046.e1.</Citation></Reference><Reference><Citation>Lizardo DY, Kuang C, Hao S, Yu J, Huang Y, Zhang L. Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: from bench to bedside. Biochim Biophys Acta Rev Cancer. 2020;1874:188447.</Citation></Reference><Reference><Citation>Andr&#xe9; T, Shiu KK, Kim TW, et al.; KEYNOTE-177 Investigators. Pembrolizumab in microsatellite-instability&#x2013;high advanced colorectal cancer. N Engl J Med. 2020;383:2207&#x2013;2218.</Citation></Reference><Reference><Citation>Chalabi M, Fanchi LF, Dijkstra KK, et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat Med. 2020;26:566&#x2013;576.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27571671</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1699-5198</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>Jul</Month><Day>19</Day></PubDate></JournalIssue><Title>Nutricion hospitalaria</Title><ISOAbbreviation>Nutr Hosp</ISOAbbreviation></Journal><ArticleTitle>[Not Available].</ArticleTitle><Pagination><StartPage>396</StartPage><MedlinePgn>396</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.20960/nh.396</ELocationID><Abstract><AbstractText>Introducci&#xf3;n: las lesiones intraepiteliales escamosas (LIE) son un estado de transici&#xf3;n hacia el c&#xe1;ncer cervicouterino (CaCu) y un d&#xe9;ficit de micronutrientes puede acelerar este proceso. Por ello, determinar la existencia de este d&#xe9;ficit y conocer qu&#xe9; factores se asocian permitir&#xed;a una posible prevenci&#xf3;n en esta poblaci&#xf3;n de riesgo.Objetivo: determinar la presencia de alguna deficiencia de micronutrientes involucrados en el proceso anticancer&#xed;geno y asociar este d&#xe9;ficit con h&#xe1;bitos y factores demogr&#xe1;ficos en pacientes con LIE de Ciudad Ju&#xe1;rez, Chihuahua, M&#xe9;xico.M&#xe9;todos:en un estudio transversal anal&#xed;tico fueron seleccionadas 102 pacientes con LIE. Se realiz&#xf3; una encuesta dietar&#xed;a (recordatorio de 24 horas) para estimar la ingesta de micronutrientes. La deficiencia fue determinada con un consumo &lt; 75% de la ingesta diaria recomendada&#xa0;o sugerida (IDR o IDS) en M&#xe9;xico. Algunos h&#xe1;bitos y factores demogr&#xe1;ficos fueron obtenidos mediante la entrevista con la paciente. Se realiz&#xf3; un modelo de regresi&#xf3;n log&#xed;stica para asociar la presencia de deficiencia con factores que afectan a la ingesta o incrementan el requerimiento de micronutrientes.Resultados:el retinol, &#xe1;cido f&#xf3;lico, zinc, vitaminas C y E, considerados como micronutrientes en el proceso anticancer&#xed;geno del CaCu, se encontraron por debajo del 75% de la IDR. Aquellas mujeres con sobrepeso, obesidad y amas de casa se asociaron significativamente con la deficiencia de micronutrientes.Conclusi&#xf3;n: el sobrepeso, la obesidad y la ocupaci&#xf3;n han sido asociados para presentar deficiencias de micronutrientes en este estudio. Estas variables convergen en una posible inseguridad alimentaria, la cual podr&#xed;a asociarse al incremento de incidencia de CaCu en M&#xe9;xico.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arellano Ortiz</LastName><ForeName>Ana Lidia</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Instituto de Ciencias Biom&#xe9;dicas. Universidad Aut&#xf3;noma de Ciudad Ju&#xe1;rez. fjimenez@uacj.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez Vega</LastName><ForeName>Florinda</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>D&#xed;az Hern&#xe1;ndez</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Salcedo Vargas</LastName><ForeName>Muricio</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>De la Mora Covarrubias</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>L&#xf3;pez D&#xed;az</LastName><ForeName>Jos&#xe9; Alberto</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Vargas Requena</LastName><ForeName>Claudia Luc&#xed;a</ForeName><Initials>CL</Initials></Author><Author ValidYN="Y"><LastName>Cass&#xed;s Nosthas</LastName><ForeName>Mar&#xed;a Lorena</ForeName><Initials>ML</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Deficiencia de micronutrientes en la dieta del paciente con lesiones precancerosas del c&#xe9;rvix de una cl&#xed;nica de colposcop&#xed;a en Ciudad Ju&#xe1;rez, M&#xe9;xico.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Nutr Hosp</MedlineTA><NlmUniqueID>9100365</NlmUniqueID><ISSNLinking>0212-1611</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018977">Micronutrients</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004032" MajorTopicYN="Y">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008800" MajorTopicYN="N">Mexico</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018977" MajorTopicYN="N">Micronutrients</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050177" MajorTopicYN="N">Overweight</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011230" MajorTopicYN="N">Precancerous Conditions</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002583" MajorTopicYN="N">Uterine Cervical Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C&#xe1;ncer cervicouterino. Lesiones intraepiteliales escamosas. Micronutrientes. Ingesta diaria recomendada.</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27571671</ArticleId><ArticleId IdType="doi">10.20960/nh.396</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>